REVVITY INC

For the period ended Sep 29, 2024. Filed Nov 6, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 29, 2024 · Filed Nov 6, 2024

RVTY$159.10-1.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Cash Flows

	Nine Months Ended
	September 29,2024	October 1,2023
(In thousands)
Operating activities:
Net income	$175,740	$614,531
Loss (income) from discontinued operations, net of income taxes	18,948	(498,595)
Income from continuing operations	194,688	115,936
Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:
Stock-based compensation	32,756	34,229
Restructuring and other costs, net	22,119	15,936
Depreciation and amortization	322,816	326,201
Change in fair value of contingent consideration	6,006	1,718
Amortization of deferred debt financing costs and accretion of discounts	5,051	5,800
Change in fair value of financial securities	(13,975)	12,842
Debt extinguishment gain	—	(3,422)
Unrealized foreign exchange (gain) loss	(1,063)	23,679
Changes in assets and liabilities which provided (used) cash:
Accounts receivable, net	33,291	(30,913)
Inventories	26,817	(34,834)
Accounts payable	(24,782)	(85,394)
Accrued expenses and other	(114,236)	(322,995)
Net cash provided by operating activities of continuing operations	489,488	58,783
Net cash used in operating activities of discontinued operations	(35,419)	(164,124)
Net cash provided by (used in) operating activities	454,069	(105,341)
Investing activities:
Capital expenditures	(62,194)	(57,252)
Purchases of investments and notes receivables	(4,337)	(6,000)
Proceeds from investments and notes receivables	2,500	—
Purchases of marketable securities	—	(831,219)
Proceeds from marketable securities	710,000	550,000
Proceeds from disposition of businesses and assets	—	153
Cash paid for acquisitions, net of cash acquired	—	(2,086)
Net cash provided by (used in) investing activities of continuing operations	645,969	(346,404)
Net cash provided by investing activities of discontinued operations	147,522	2,074,734
Net cash provided by investing activities	793,491	1,728,330
Financing activities:
Payments of senior unsecured notes	(711,479)	(517,973)
Payments of debt financing and equity issuance costs	—	(15)
Net (payments) proceeds of other credit facilities	(10,771)	7,218
Payments for acquisition-related contingent consideration	(8,832)	(10,117)
Proceeds from issuance of common stock under stock plans	6,173	3,721
Purchases of common stock	(184,421)	(384,014)
Dividends paid	(25,915)	(26,327)
Net cash used in financing activities	(935,245)	(927,507)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	4,120	(28,270)

Supplemental disclosures of cash flow information
Net increase in cash, cash equivalents and restricted cash	316,435	667,212
Cash, cash equivalents and restricted cash at beginning of period	914,373	470,746
Cash, cash equivalents and restricted cash at end of period	$1,230,808	$1,137,958
Reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total shown in the condensed consolidated statements of cash flows:
Cash and cash equivalents	$1,229,778	$1,136,721
Restricted cash included in other current assets	1,030	1,237
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	$1,230,808	$1,137,958
Supplemental disclosures of non-cash investing and financing activities:
Consideration receivable from sale of business	$—	$261,317

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.